Seeking Alpha

The cost of caring for people with dementia is $157-215B a year and could double by 2040, a...

The cost of caring for people with dementia is $157-215B a year and could double by 2040, a study from RAND Corp. estimates. The cost of dementia treatment is $109B - above the $102B spent on heart disease and the $77B on cancer - with the other dementia expenses used for long-term day-to-day care. Companies that develop drugs for Alzheimer's disease and other conditions include Pfizer (PFE), Eli Lilly (LLY), J&J (JNJ) and Merck (MRK).
Comments (5)
  • We saved money all our lives on cheap processed foods and are now paying for it on the back end...
    4 Apr 2013, 07:41 AM Reply Like
  • LOL! we save and save and save our whole lives only to end up living with half a brain in a closet somewhere, and paying the same price as a Manhattan apartment without the view. Isn't life grand! I would prefer to live better now not longer.
    4 Apr 2013, 10:13 AM Reply Like
  • And exactly how useful are the current drugs (other than to Pharma's bottom line)?
    4 Apr 2013, 10:18 AM Reply Like
  • Current drugs are ABSOLUTELY useless for people with dementia but can make life easier for the people caring for the dementing patient--mostly by immobilizing the patient through tranquilizers. None of the current drugs nor the current supported research thinking goes to root causes of Alzheimer's disease or the other dementing diseases. However, all these guilt drugs are great for big pharma's bottom line and for supporting professors and researchers and all the ancillary services of the pharma industry!
    4 Apr 2013, 01:50 PM Reply Like
  • agree
    5 Apr 2013, 04:05 AM Reply Like
DJIA (DIA) S&P 500 (SPY)